Efficacy and safety of eperisone in patients with low back pain: A double blind randomized study

European Review for Medical and Pharmacological Sciences

Volumn 12, Issue 4, 2008, Pages 229-235

  Cabitza, Paolo ^a   Randelli, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

Author keywords

Back pain; Eperisone hydrochloride; Muscle relaxant; Spinal muscle spasticity

Indexed keywords

EPERISONE; PLACEBO; THIOCOLCHICOSIDE;

ACUTE DISEASE; ADULT; ANALGESIC ACTIVITY; ARTICLE; BACK MUSCLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIARRHEA; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG SAFETY; DRUG STRUCTURE; DRUG TOLERABILITY; EPIGASTRIC DISCOMFORT; FEMALE; GASTROINTESTINAL SYMPTOM; HUMAN; LOW BACK PAIN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; MUSCLE RELAXATION; NAUSEA; PAIN ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; SCORING SYSTEM; SPASTICITY; VOMITING;

ADMINISTRATION, ORAL; ADULT; COLCHICINE; DOUBLE-BLIND METHOD; FEMALE; GASTROINTESTINAL DISEASES; HUMANS; LOW BACK PAIN; MALE; MIDDLE AGED; MUSCLE RELAXANTS, CENTRAL; PAIN MEASUREMENT; PARASYMPATHOLYTICS; PROPIOPHENONES;

EID: 49549091165     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. CHOU R, HUFFMAN LH, AMERICAN PAIN SOCIETY, AMERICAN COLLEGE OF PHYSICIANS. Medications for acute and chronic low back pain: A review of the evidence for an American Pain Society/American College of Physicians clinical practice guideline. Ann Intern Med 2007; 147: 505-514.
2. GÓRSKA J. Effects of back pain treatment with tizanidine. Orthop Traumatol Rehabil 2005; 7: 306-309.
3. MALANGA GA, DENNIS RL. Use of medications in the treatment of acute low back pain. Clin Occup Environ Med 2006; 5: 643-653.
4. MELLINGHOFF H. Modern muscle relaxants and their clinical application. Anaesthesist 1994; 43: 270-282.
5. BERNSTEIN E, CAREY TS, GARRETT JM. The use of muscle relaxant medications in acute low back pain. Spine 2004; 29: 1346-1351.
6. DILLON C, PAULOSE-RAM R, HIRSCH R, GU O. Skeletal muscle relaxant use in the United States: Data from the Third National Health and Nutrition Examination Survey (NHANES III). Spine 2004; 29: 892-896.
7. NAKAGAWA M, NAKAHARA K, MARUYAMA Y, KAWABATA M, HIGUCHI I, KUBOTA H, IZUMO S, ARIMURA K, OSAME M. Therapeutic trials in 200 patients with HTLV-I-associated myelopathy/tropical spastic paraparesis. J Neurovirol 1996; 2: 345-355.
8. MURAYAMA K, KATSUMI T, TAJIKA E, NAKAMURA T. Clinical application of eperisone hydrochloride to neurogenic bladder. Hinyokika Kiyo 1984; 30: 403-408.
9. BOSE K. The efficacy and safety of eperisone in patients with cervical spondylosis: Results of a randomized, double-blind, placebo-controlled trial. Method Find Exp Clin Pharmacol 1999; 21: 209-213.
10. TARIO M, AKHTAR N, ALI M, RAO S, BADSHAH M, IRSHAD M. Eperisone compared to physiotherapy on muscular tone of stroke patients: A prospective randomized open study. J Pak Med Assoc 2005; 55: 202-204.
11. KOBAYASHI Y, KAWASAKI T, YOSHIMI T, NAKAJIMA T, KANAI K. Muscle cramps in chronic liver diseases and treatment with antispastic agent (eperisone hydrochloride). Dig Dis Sci 1992; 37: 1145-1146.
12. TÜZÜN F, UNALAN H, ONER N, OZGÜZEL H, KIRAZLI Y, IÇAǦASIOǦLU A, KURAN B, Tüzün S, BASAR G. Multicenter, randomized, double-blinded, placebo-controlled trial of thiocolchicoside in acute low back pain. Joint Bone Spine 2003; 70: 356-361.
13. MARCEL C, REZVANI Y, REVEL M. Evaluation of thiocolchicoside as monotherapy in low back pain. Results of a randomized study versus placebo. Presse Med 1990; 19: 1133-1136.
14. TANAKA K, KANEKO T, YAMATSU K. Effects of 4′-ethyl-2-methyl-3-piperidinopropriophenone on experimental rigidity and spinal cord activity. Folia Pharmacol Jpn 1981; 77: 511-520.
15. MANO T, MIYAOKA T. Effects of muscle relaxant E.M.P.P. on afferent discharges of muscle spindle in man: An microneurographic analysis. No To Shinkei 1981; 33: 237-241.
16. FUJIOKA Y, KURIYAMA H. Eperisone, an antispastic agent, possesses vasodilating actions on the guinea-pig basilar artery. J Pharmacol Exp Ther 1985; 235: 757-763.
17. INOUE S, BIAN K, OKAMURA T, OKUNISHI H, TODA N. Mechanisms of action of eperisone on isolated dog saphenous arteries and veins. Jpn J Pharmacol 1989; 50: 271-282.
18. IWASE S, MANO T, SALTO M, ISHIDA G. Effect of a centrally-acting muscle relaxant, eperisone hydrochloride, on muscle sympathetic nerve activity in humans. Funct Neurol 1992; 7: 459-470.
19. GRAVEN-NIELSEN T, JANSSON Y, SEGERDAHL M, KRISTENSEN JD, MENSE S, ARENDT-NIELSEN L, SOLLEVI A. Experimental pain by ischaemic contractions compared with pain by intramuscular infusions of adenosine and hypertonic saline. Eur J Pain 2003; 7: 93-102.
20. YABUKI S, KIKUCHI S, MIDORIKAWA H, HOSHINO S. Vascular backache and consideration of its pathomechanisms: Report of two cases. J Spinal Disord 1999; 12: 162-167